Table 4.
Clinical characteristics and outcomes of COVID-19 patients with or without AKI.
| AKI | no AKI | P value | |
|---|---|---|---|
| N (%); | 115 (6.7) | 1593 (93.27) | - |
| Age (years); | 69 (63,77) | 62 (50,70) | 0.000 |
| Male sex, n/N (%); | 60/115 (52.17) | 758/1593 (47.58) | 0.341 |
| Disease severity, n/N (%) | |||
| Non-severe | 39/115 (33.91) | 1080/1593 (67.80) | 0.000 |
| Severe | 76/115 (66.09) | 511/1593 (32.08) | 0.000 |
| Comorbidities | |||
| Hypertension | 69/115 (60.00) | 577/1593 (36.22) | 0.000 |
| Diabetes | 25/115 (21.74) | 263/1593 (16.51) | 0.148 |
| Coronary artery heart disease | 20/115 (17.39) | 163/1593 (10.23) | 0.017 |
| Chronic kidney disease | 10/115 (8.70) | 33/1593 (2.07) | 0.000 |
| eGFR at admission | 96.7 (78.0, 110.2) | 100.8 (89.7, 112.4) | 0.010 |
| Any complication, n/N (%) | 115/115 (100.00) | 1235/1593 (77.53) | 0.001 |
| Day of hospitalization when AKI occurred (days) | 8 (5, 14) | - | - |
| Death, n/N (%) | 37/115 (32.17) | 39/1593 (2.45) | 0.000 |
| ICU admission, n/N (%) | 51/115 (44.35) | 149/1593 (9.35) | 0.000 |
| Mechanical ventilation, n/N (%) | 37/115 (32.17) | 41/1593 (2.57) | 0.000 |
| Composite endpoint, n/N (%) | 54/115 (46.96) | 151/1593 (9.48) | 0.000 |